-
公开(公告)号:US11141402B2
公开(公告)日:2021-10-12
申请号:US16619218
申请日:2018-06-05
发明人: Peter Edward Lobie , Vijay Kumar Pandey , Rangappa Kanchugarakoppal Subbegowda , Basappa , Mohan Chakrabhavi Dhananjaya , Shobith Rangappa
IPC分类号: A61K31/37 , A61K31/4433 , A61K45/06 , C07D493/04
摘要: Disclosed herein are compounds of Formula I, wherein A, R1 to R6, and x to z have the meanings given in the description.
-
公开(公告)号:US11292773B2
公开(公告)日:2022-04-05
申请号:US16605630
申请日:2018-04-18
发明人: Peter Edward Lobie , Vijay Kumar Pandey , Rangappa Kanchugarakoppal Subbegowda , Bassappa Salundi , Mohan Chakrabhavi Dhananjaya , Shobith Rangappa , Srinivasa Venkatachalaiah
IPC分类号: C07D241/04 , A61P35/00 , C07D405/06 , C07D409/06 , C07D413/04 , C07D471/06 , C07D213/53 , C07D295/096 , C07D295/155 , C07D295/192 , C07D307/52 , C07D333/20 , A61K31/495 , A61K31/496
摘要: The invention relates to compounds of general formula (I): wherein R1, n, R2a, R2b, and R3 are as defined herein. The compounds are inhibitors of Bcl-2-associated death promoter (BAD) phosphorylation and have anti-apoptotic activity and are useful in the treatment of cancer, particularly breast cancer, endometrial cancer, ovarian cancer, liver cancer, colon cancer, prostate cancer or pancreatic cancer.
-